Suchergebnisse - "Liangshun You"

PubPharm (12)

1

When idiopathic multicentric Castleman disease meets COVID-19: a multicenter retrospective study from China

in: Therapeutic Advances in Hematology | 2024

von Yi Liu | Xuejiao Yin | Dan Xu | +8

2

Harnessing Nanotechnology: Emerging Strategies for Multiple Myeloma Therapy

in: Biomolecules | 2024

von Min Yang | Yu Chen | Li Zhu | +5

3

Bispecific antibody treatment of multiple myeloma: latest updates from the 2022 ASH annual meeting

in: Therapeutic Advances in Chronic Disease | 2023

von Xuejiao Yin | Yi Liu | Jianai Sun | +3

4

Bispecific T cell engagers targeting CD20/CD3 in B-cell lymphoma: latest updates from 2023 EHA annual meeting

in: Therapeutic Advances in Chronic Disease | 2023

von Shenhe Jin | Yi Liu | Ye Zhang | +3

5

The mechanisms and cross-protection of trained innate immunity

in: Virology Journal | 2022

von Shiwei Hu | Danhong Xiang | Xinlu Zhang | +5

6

Role of Radiation Therapy in Mortality among Adolescents and Young Adults with Lymphoma: Differences According to Cause of Death

in: Cancers | 2022

von Xuejiao Yin | Liangshun You | Xuelian Hu

7

Decitabine-Mediated Epigenetic Reprograming Enhances Anti-leukemia Efficacy of CD123-Targeted Chimeric Antigen Receptor T-Cells

in: Frontiers in Immunology | 2020

von Liangshun You | Liangshun You | Liangshun You | +15

8

Gut Microbiome and Metabolome Were Altered and Strongly Associated With Platelet Count in Adult Patients With Primary Immune Thrombocytopenia

in: Frontiers in Microbiology | 2020

von Xuewu Zhang | Xuewu Zhang | Xuewu Zhang | +17

9

Global, Regional, and National Burden of Chronic Myeloid Leukemia, 1990–2017: A Systematic Analysis for the Global Burden of Disease Study 2017

in: Frontiers in Oncology | 2020

von Qingqing Lin | Qingqing Lin | Liping Mao | +13

10

Duration of serum neutralizing antibodies for SARS-CoV-2: Lessons from SARS-CoV infection

in: Journal of Microbiology, Immunology and Infection | 2020

von Qingqing Lin | Li Zhu | Zuowei Ni | +2